• Info
  • Insider Ownership

Insider Trading & Ownership of JAMES M. FRATES

Location
Cambridge, MA
Summary
The estimated net worth of JAMES M. FRATES is at least $2,675,570 dollars as of 04 Feb 2026. JAMES M. FRATES is the Chief Financial Officer of Amylyx Pharmaceuticals, Inc. and owns shares of Amylyx Pharmaceuticals, Inc. (AMLX) stock worth about $2.68M.
Signature
/s/ Joshua B. Cohen, as Attorney in Fact
All Insider Reports
All Insider Reports

Notify me when JAMES M. FRATES files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of JAMES M. FRATES

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
AMLX Amylyx Pharmaceuticals, Inc. Chief Financial Officer $2,675,570 -$281,507 -9.5% 02 Feb 2026
SAGE Sage Therapeutics, Inc. Director $0 31 Jul 2025

Insider Transactions Reported by JAMES M. FRATES:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.